Skip to main content
OpenTrials

Clinical trial condition

Scleroderma

Explore clinical trials studying Scleroderma. Study availability and eligibility vary by location and protocol.

119 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma trial results

Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

NCT05098704

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +4 more
Locations
  • CH de la Cote Basque - service de rhumatologie Bayonne, France
  • CHU de Bordeaux - service de Médecine Interne et Maladies Infectieuses Bordeaux, France
  • CHU de Bordeaux - service de rhumatologie Bordeaux, France
  • CHU de Brest - service de rhumatologie Brest, France
View Trial Details
Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

NCT06991114

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Artiva Investigational Site Tuscaloosa Tuscaloosa, Alabama, United States
  • Artiva Investigational Site Phoenix Phoenix, Arizona, United States
  • Artiva Investigational Site Tucson Tucson, Arizona, United States
  • Artiva Investigational Site Chula Vista Chula Vista, California, United States
View all 52 locations
View Trial Details
Recruiting

Platform Clinical Study for Conquering Scleroderma

NCT06195072

Conditions
Connective Tissue Diseases, Interstitial Lung Disease Due to Systemic Disease, Lung Diseases, +7 more
Locations
  • University of Alabama - Division of Pulmonary and Critical Care Medicine Birmingham, Alabama, United States
  • Keck School of Medicine at USC Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Ronald Reagan Medical Center Los Angeles, California, United States
View all 34 locations
View Trial Details

Related conditions